Blis sees 'modest' earnings surplus after more than doubling first-half sales

Paul McBeth
Wed, 14 Oct 2015

By Paul McBeth Oct. 14 (BusinessDesk) - Blis Technologies, which sells probiotic products targeted at oral health, colds and flu, expects to post "modest" earnings after more than doubling first-half sales, which it anticipates will flow into the annual result. The Dunedin-based company will report a "modest surplus" in earnings before interest, tax, depreciation and amortisation and a small net loss in the six months ended Sept. 30 after lifting sales 139 percent to $2.7 million, it said in a statement after the close of trading. That is...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Law & Regulation FREE
Cigna admits to wrongly lifting customers' cover and premiums
Ella Somers | Wed, 10 Aug 2022

Cigna Life Insurance has admitted to misleading more than 52,000 customers.

Listed Companies
ASX company assures it was aware of risks in buying TTR
Greg Hurrell | Wed, 10 Aug 2022

Three days after Australian mining company Manuka Resources Limited announced it was acquiring Trans-Tasman Resources Limited, a private members bill that could scupper its seabed mining hopes was drawn from the ballot.

Listed Companies
Millennium & Copthorne Hotels targets annual profit as pandemic bites
Riley Kennedy | Wed, 10 Aug 2022

The hotel operator recorded a net profit of $15.4 million for the six months to June 30.

Sponsored
A clearer path to the cloud

Step-by-step cloud transition can bring benefits, experts say.

Sponsored
Energy of the future: Why we need innovation

The Tomorrow’s Energy Today conference is looking at ways to develop a clean, affordable and reliable energy future, says Brendan Winitana, chair of the Sustainable Energy Association New Zealand (SEANZ).